Marc Schläppi

Statistics

Publications

Citations

222

H-Index

Active since

2011

Affiliations

University Hospital of Zurich(Current)

Swiss Group For Clinical Cancer Research

Hôpital Orthopédique de la Suisse Romande

University Hospital of Bern

Marc Schläppi is an author at University Hospital of Zurich specializing in metastatic disease treatment, melanoma pharmacotherapy, and metastatic melanoma treatment.

Publications per year

2011–2017

Publications

World Congress Integrative Medicine & Health 2017: Part one

Torkel Falkenberg, Stefan N. Willich, Josephine P. Briggs et al. · BMC Complementary and Alternative Medicine · 2017 · 116 citations · Full text

Health Professions, Health Sciences, Clinical Medicine +6

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Roger von Moos, Burkhardt Seifert, Mathew Simcock et al. · Annals of Oncology · 2011 · 75 citations · Full text

Medicine, Oncology, Pharmacology +13

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

Peter Schraml, Adriana von Teichman, Daniela Mihic‐Probst et al. · Oncology Reports · 2012 · 31 citations · Full text

Medicine, Genetics, Oncology +17

1–3 of 3